Sponsor Pipeline

Rondo Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
7
Disease Areas
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07218003 A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder… Non Small Cell Lung Cancer Enrolling by Invitation
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Breast Cancer (1) Triple-Negative Breast Cancer (1) Gastric Cancer (1) Bladder Cancer (1) Cervical Cancer (1)
Get alerts when Rondo Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free